JP Morgan sees a limited 1-2 percent impact on Sun Pharma#39;s FY24 earnings due to the production halt.
JP Morgan sees a limited 1-2 percent impact on Sun Pharma#39;s FY24 earnings due to the production halt. JP Morgan sees a limited 1-2 percent impact on Sun Pharma#39;s FY24 earnings due to the production halt. Moneycontrol Latest News Read More
